Cirrhosis in over 16s: assessment and management (NG50)Product type:GuidanceProgramme:NICE guidelineLast updated: 8 September 2023Published: 6 July 2016
FibroScan for assessing liver fibrosis and cirrhosis outside secondary and specialist care (DG48)Product type:GuidanceProgramme:Diagnostics guidancePublished: 7 June 2023
Tunnelled peritoneal drainage catheter insertion for refractory ascites in cirrhosis (IPG746)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 23 November 2022
Subcutaneous automated low-flow pump implantation for refractory ascites caused by cirrhosis (IPG631)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 14 November 2018
Alcohol-use disorders: diagnosis and management of physical complications (CG100)Product type:GuidanceProgramme:Clinical guidelineLast updated: 12 April 2017Published: 2 June 2010
Living-donor liver transplantation (IPG535)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 25 November 2015
Rifaximin for preventing episodes of overt hepatic encephalopathy (TA337)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 25 March 2015
Nalmefene for reducing alcohol consumption in people with alcohol dependence (TA325)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 26 November 2014
Alcohol-use disorders: diagnosis, assessment and management of harmful drinking (high-risk drinking) and alcohol dependence (CG115)Product type:GuidanceProgramme:Clinical guidelineLast updated: 21 October 2014Published: 23 February 2011
Alcohol-use disorders: prevention (PH24)Product type:GuidanceProgramme:Public health guidelinePublished: 2 June 2010
Extracorporeal albumin dialysis for acute liver failure (IPG316)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 23 September 2009